Tenders Are Invited For Finished Medicinal Products With The Active Ingredient Erythropoietin (Atc Code: B03 ...

Work Detail

Contract Notice: Finished Medicinal Products With The Active Ingredient Erythropoietin (Atc Code: B03xa01 - In The Effective Strength Over 10,000 Ie Per Dosing Unit) Pharmaceutical Products Short Description: The Subject Of This Publication Is The Conclusion Of Non-Exclusive Discount Contracts According To Section 130A (8) Sgb V For Finished Medicinal Products With The Active Ingredient Erythropoietin (Atc Code: B03xa01- In The Effectiveness Of Over 10,000 Ie Per Dosing Unit) As Part Of A So-Called Open- House Model . Under The Specification Of Uniform Contractual Conditions And Uniform Access Procedures, All Suitable And Interested Pharmaceutical Companies Or Communities Of Pharmaceutical Companies Is Offered The Conclusion Or Accession To A Discount Contract According To §130 A (8) Sgb V For The Active Ingredients Mentioned Under Section B. Interested Pharmaceutical Companies Can Request The Participation Documents And The Respective Contract With The Contact Address Mentioned Under I.1). The Prerequisite For The Conclusion Of A Contract Is That The Interested Pharmaceutical Company Fully Filled And Signed The Requested Participation Documents. Deadline For Submission: 20240828 00:00 Type Of Buyer: Body Governed By Public Law Type Of Contract: Supplies Type Of Procedure: Open Procedure Regulation: European Union Type Of Bid: Submission For All Lots Award Criteria: The Most Economic Tender [Disclaimer: The Above Text Is Machine Translated. For Accurate Information Kindly Refer The Original Document.] Tender Link : Https://Ted.Europa.Eu/Udl?Uri=Ted:Notice:518403-2022:Data:En:Html

Contact Information

Other Detail